XML 18 R7.htm IDEA: XBRL DOCUMENT v3.20.4
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK, REDEEMABLE CONVERTIBLE CLASS A-1 COMMON STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Initial Public Offering and Private Placements
Common Stock
Common Stock
Initial Public Offering and Private Placements
Additional Paid-In Capital
Additional Paid-In Capital
Initial Public Offering and Private Placements
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Redeemable Convertible Preferred Stock
Series G Preferred Stock
Series H Preferred Stock
Redeemable Convertible A-1 Common Stock
Beginning Balance, shares (in shares) at Apr. 30, 2019                 34,192,000     6,667,000
Beginning Balance, Amount at Apr. 30, 2019                 $ 299,965     $ 18,800
Increase (Decrease) in Temporary Equity [Roll Forward]                        
Issuance of Preferred Stock, net of issuance costs (in shares)                   1,283,000 1,654,000  
Issuance of Preferred Stock, net of issuance costs                   $ 25,406 $ 49,836  
Ending Balance, shares (in shares) at Jan. 31, 2020                 37,129,000     6,667,000
Ending Balance, Amount at Jan. 31, 2020                 $ 375,207     $ 18,800
Beginning Balance, shares (in shares) at Apr. 30, 2019     20,057,000                  
Beginning Balance, Amount at Apr. 30, 2019 $ (165,434)   $ 20   $ 58,731   $ 74 $ (224,259)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Issuance of common stock (in shares)     9,530,000                  
Issuance of common stock 44,027   $ 10   44,017              
Issuance of Class A common stock upon exercise of stock options (in shares)     1,630,000                  
Issuance of Class A common stock upon exercise of stock options 2,015   $ 1   2,014              
Vesting of early exercised Class A common stock options 427       427              
Tender offer repurchases (in shares)     (164,000)                  
Tender offer repurchases (3,548)   $ (1)   (3,547)              
Stock-based compensation expense 5,424       5,424              
Other comprehensive income (loss) 136           136          
Net loss (38,944)             (38,944)        
Ending Balance, shares (in shares) at Jan. 31, 2020     31,053,000                  
Ending Balance, Amount at Jan. 31, 2020 (155,897)   $ 30   107,066   210 (263,203)        
Beginning Balance, shares (in shares) at Apr. 30, 2019                 34,192,000     6,667,000
Beginning Balance, Amount at Apr. 30, 2019                 $ 299,965     $ 18,800
Ending Balance, shares (in shares) at Apr. 30, 2020                 37,128,768     6,666,665
Ending Balance, Amount at Apr. 30, 2020                 $ 375,207     $ 18,800
Beginning Balance, shares (in shares) at Apr. 30, 2019     20,057,000                  
Beginning Balance, Amount at Apr. 30, 2019 (165,434)   $ 20   58,731   74 (224,259)        
Ending Balance, shares (in shares) at Apr. 30, 2020     31,210,000                  
Ending Balance, Amount at Apr. 30, 2020 (182,697)   $ 31   110,485   424 (293,637)        
Beginning Balance, shares (in shares) at Oct. 31, 2019                 37,129,000     6,667,000
Beginning Balance, Amount at Oct. 31, 2019                 $ 375,207     $ 18,800
Ending Balance, shares (in shares) at Jan. 31, 2020                 37,129,000     6,667,000
Ending Balance, Amount at Jan. 31, 2020                 $ 375,207     $ 18,800
Beginning Balance, shares (in shares) at Oct. 31, 2019     30,779,000                  
Beginning Balance, Amount at Oct. 31, 2019 (148,833)   $ 30   104,403   141 (253,407)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Issuance of common stock (in shares)     274,000                  
Issuance of common stock 446       446              
Vesting of early exercised Class A common stock options 156       156              
Stock-based compensation expense 2,061       2,061              
Other comprehensive income (loss) 69           69          
Net loss (9,796)             (9,796)        
Ending Balance, shares (in shares) at Jan. 31, 2020     31,053,000                  
Ending Balance, Amount at Jan. 31, 2020 (155,897)   $ 30   107,066   210 (263,203)        
Beginning Balance, shares (in shares) at Apr. 30, 2020                 37,128,768     6,666,665
Beginning Balance, Amount at Apr. 30, 2020                 $ 375,207     $ 18,800
Increase (Decrease) in Temporary Equity [Roll Forward]                        
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)                 (37,129,000)     (6,667,000)
Conversion of redeemable convertible preferred stock to common stock upon initial public offering                 $ (399,753)     $ (18,800)
Repayment of shareholder loan                 $ 24,546      
Ending Balance, shares (in shares) at Jan. 31, 2021                 0     0
Ending Balance, Amount at Jan. 31, 2021                 $ 0     $ 0
Beginning Balance, shares (in shares) at Apr. 30, 2020     31,210,000                  
Beginning Balance, Amount at Apr. 30, 2020 (182,697)   $ 31   110,485   424 (293,637)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)     43,796,000                  
Conversion of redeemable convertible preferred stock to common stock upon initial public offering 418,553   $ 44   418,509              
Repayment of shareholder loan $ 1,457       1,457              
Issuance of common stock (in shares)       21,396,000                
Issuance of common stock   $ 844,646   $ 21   $ 844,625            
Issuance of Class A common stock upon exercise of stock options (in shares) 4,563,000   4,530,000                  
Issuance of Class A common stock upon exercise of stock options $ 7,867   $ 5   7,862              
Vesting of early exercised Class A common stock options 2,073       2,073              
Stock-based compensation expense 14,270       14,270              
Other comprehensive income (loss) (411)           (411)          
Net loss $ (31,646)             (31,646)        
Ending Balance, shares (in shares) at Jan. 31, 2021 3,499,992   100,932,000                  
Ending Balance, Amount at Jan. 31, 2021 $ 1,074,112   $ 101   1,399,281   13 (325,283)        
Beginning Balance, shares (in shares) at Oct. 31, 2020                 37,129,000     6,667,000
Beginning Balance, Amount at Oct. 31, 2020                 $ 399,753     $ 18,800
Increase (Decrease) in Temporary Equity [Roll Forward]                        
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)                 (37,129,000)     (6,667,000)
Conversion of redeemable convertible preferred stock to common stock upon initial public offering                 $ (399,753)     $ (18,800)
Ending Balance, shares (in shares) at Jan. 31, 2021                 0     0
Ending Balance, Amount at Jan. 31, 2021                 $ 0     $ 0
Beginning Balance, shares (in shares) at Oct. 31, 2020     32,981,000                  
Beginning Balance, Amount at Oct. 31, 2020 (184,327)   $ 33   124,009   62 (308,431)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)     43,796,000                  
Conversion of redeemable convertible preferred stock to common stock upon initial public offering 418,553   $ 44   418,509              
Issuance of common stock (in shares)       21,396,000                
Issuance of common stock   $ 844,646   $ 21   $ 844,625            
Issuance of Class A common stock upon exercise of stock options (in shares)     2,759,000                  
Issuance of Class A common stock upon exercise of stock options 4,803   $ 3   4,800              
Vesting of early exercised Class A common stock options 749       749              
Stock-based compensation expense 6,589       6,589              
Other comprehensive income (loss) (49)           (49)          
Net loss $ (16,852)             (16,852)        
Ending Balance, shares (in shares) at Jan. 31, 2021 3,499,992   100,932,000                  
Ending Balance, Amount at Jan. 31, 2021 $ 1,074,112   $ 101   $ 1,399,281   $ 13 $ (325,283)